Search research articles
Contact Us
Filters
Showing results (161-170 of 276) with videos related to
Page
of 28
Sort By:
Nature Immunology
|
January 29, 2002
Role of ICAM-3 in the initial interaction of T lymphocytes and APCs
María C Montoya, David Sancho, Grégory Bonello, et al.
Cancer Immunology, Immunotherapy : CII
|
August 13, 2016
Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4
Marc Lopez, Abderrezak Ghidouche, Caroline Rochas, et al.
The Journal of Experimental Medicine
|
May 5, 2017
Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells
Zakia Djaoud, Lisbeth A Guethlein, Amir Horowitz, et al.
Human Immunology
|
October 4, 2008
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells
Daniela Fenoglio, Francesca Ferrera, Marco Fravega, et al.
Cells
|
July 14, 2023
Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells
Anne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, et al.
European Journal of Immunology
|
April 8, 2017
Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation
Lisa Starick, Felipe Riano, Mohindar M Karunakaran, et al.
Plos Pathogens
|
August 22, 2009
CpG methylation controls reactivation of HIV from latency
Jana Blazkova, Katerina Trejbalova, Françoise Gondois-Rey, et al.
Cancers
|
June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor
Raynier Devillier, Boris Calmels, Sophie Guia, et al.
BMC Cancer
|
May 2, 2023
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study
Gwenaelle Gravis, Patricia Marino, Daniel Olive, et al.
Frontiers in Immunology
|
August 27, 2019
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
Alessandra Marrella, Alessandra Dondero, Maurizio Aiello, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 276) with videos related to
Sort By:
Page
of 28
Nature Immunology
|
January 29, 2002
Role of ICAM-3 in the initial interaction of T lymphocytes and APCs
María C Montoya, David Sancho, Grégory Bonello, et al.
Cancer Immunology, Immunotherapy : CII
|
August 13, 2016
Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4
Marc Lopez, Abderrezak Ghidouche, Caroline Rochas, et al.
The Journal of Experimental Medicine
|
May 5, 2017
Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells
Zakia Djaoud, Lisbeth A Guethlein, Amir Horowitz, et al.
Human Immunology
|
October 4, 2008
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells
Daniela Fenoglio, Francesca Ferrera, Marco Fravega, et al.
Cells
|
July 14, 2023
Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells
Anne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, et al.
European Journal of Immunology
|
April 8, 2017
Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation
Lisa Starick, Felipe Riano, Mohindar M Karunakaran, et al.
Plos Pathogens
|
August 22, 2009
CpG methylation controls reactivation of HIV from latency
Jana Blazkova, Katerina Trejbalova, Françoise Gondois-Rey, et al.
Cancers
|
June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor
Raynier Devillier, Boris Calmels, Sophie Guia, et al.
BMC Cancer
|
May 2, 2023
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study
Gwenaelle Gravis, Patricia Marino, Daniel Olive, et al.
Frontiers in Immunology
|
August 27, 2019
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
Alessandra Marrella, Alessandra Dondero, Maurizio Aiello, et al.
Page
of 28